162 related articles for article (PubMed ID: 7499434)
1. Binding of tenascin-C to soluble fibronectin and matrix fibrils.
Chung CY; Zardi L; Erickson HP
J Biol Chem; 1995 Dec; 270(48):29012-7. PubMed ID: 7499434
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C.
Chung CY; Erickson HP
J Cell Sci; 1997 Jun; 110 ( Pt 12)():1413-9. PubMed ID: 9217327
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin.
To WS; Midwood KS
J Biol Chem; 2011 Apr; 286(17):14881-91. PubMed ID: 21324901
[TBL] [Abstract][Full Text] [Related]
4. Involvement of chondroitin sulfates on brain-derived tenascin-R in carbohydrate-dependent interactions with fibronectin and tenascin-C.
Probstmeier R; Braunewell K; Pesheva P
Brain Res; 2000 Apr; 863(1-2):42-51. PubMed ID: 10773191
[TBL] [Abstract][Full Text] [Related]
5. A single chain variable fragment antibody (Tn 64) cognate to fibronectin type III repeats promotes corneal wound healing by inhibiting fibrosis.
Shukla A; Suresh V; Gupta PC; Sharma M; Saikia UN; Ram J; Luthra-Guptasarma M
Int Immunopharmacol; 2024 May; 133():112029. PubMed ID: 38640715
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin.
Ghert MA; Qi WN; Erickson HP; Block JA; Scully SP
Cell Struct Funct; 2001 Jun; 26(3):179-87. PubMed ID: 11565810
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue.
Hagios C; Koch M; Spring J; Chiquet M; Chiquet-Ehrismann R
J Cell Biol; 1996 Sep; 134(6):1499-512. PubMed ID: 8830777
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin.
Hauzenberger D; Olivier P; Gundersen D; Rüegg C
Eur J Immunol; 1999 May; 29(5):1435-47. PubMed ID: 10359097
[TBL] [Abstract][Full Text] [Related]
9. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues.
Chiquet-Ehrismann R; Matsuoka Y; Hofer U; Spring J; Bernasconi C; Chiquet M
Cell Regul; 1991 Nov; 2(11):927-38. PubMed ID: 1725601
[TBL] [Abstract][Full Text] [Related]
10. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins.
Day JM; Olin AI; Murdoch AD; Canfield A; Sasaki T; Timpl R; Hardingham TE; Aspberg A
J Biol Chem; 2004 Mar; 279(13):12511-8. PubMed ID: 14722076
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C matrix assembly in oral squamous cell carcinoma.
Ramos DM; Chen B; Regezi J; Zardi L; Pytela R
Int J Cancer; 1998 Mar; 75(5):680-7. PubMed ID: 9495234
[TBL] [Abstract][Full Text] [Related]
13. Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.
To WS; Midwood KS
Matrix Biol; 2010 Sep; 29(7):573-85. PubMed ID: 20708078
[TBL] [Abstract][Full Text] [Related]
14. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation.
Ma S; Yang D; Li D; Tang B; Sun M; Yang Y
Biochem Biophys Res Commun; 2011 Jun; 409(2):321-7. PubMed ID: 21586275
[TBL] [Abstract][Full Text] [Related]
15. Developmental Changes in Patterns of Distribution of Fibronectin and Tenascin-C in the Chicken Cornea: Evidence for Distinct and Independent Functions during Corneal Development and Morphogenesis.
Koudouna E; Young RD; Quantock AJ; Ralphs JR
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834965
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation.
Ikuta T; Ariga H; Matsumoto K
Genes Cells; 2000 Nov; 5(11):913-927. PubMed ID: 11122379
[TBL] [Abstract][Full Text] [Related]
17. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
[TBL] [Abstract][Full Text] [Related]
18. Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.
Weber P; Ferber P; Fischer R; Winterhalter KH; Vaughan L
FEBS Lett; 1996 Jul; 389(3):304-8. PubMed ID: 8766721
[TBL] [Abstract][Full Text] [Related]
19. Localization of a cryptic binding site for tenascin on fibronectin.
Ingham KC; Brew SA; Erickson HP
J Biol Chem; 2004 Jul; 279(27):28132-5. PubMed ID: 15123658
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.
Brösicke N; van Landeghem FK; Scheffler B; Faissner A
Cell Tissue Res; 2013 Nov; 354(2):409-30. PubMed ID: 23963648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
